What is BioIntelligence Technologies?
BioIntelligence Technologies operates at the intersection of biotechnology and industrial automation, providing critical infrastructure for the biomanufacturing sector. The company specializes in the development and commercialization of sophisticated hardware and software suites, such as the BiOptic+ and BioAnalyst platforms. These tools are engineered to provide real-time measurement of complex bioprocess variables, enabling organizations to predict outcomes, reduce operational variability, and optimize fermentation cycles. By transforming raw biological data into actionable intelligence, the firm addresses the urgent industry need for enhanced process control and long-term scalability in intelligent biomanufacturing environments.
How much funding has BioIntelligence Technologies raised?
BioIntelligence Technologies has raised a total of $5M across 1 funding round:
Other Financing Round
$5M
Other Financing Round (2024): $5M with participation from Investissement Quebec, AQC Capital, Amplify Capital, Real Ventures, and Innospark Ventures
Key Investors in BioIntelligence Technologies
Investissement Quebec
A Montreal-based organization focused on fostering economic development and job creation through strategic loans, guarantees, and equity investments.
AQC Capital
A venture firm dedicated to supporting Quebec-based startups with financial guidance and capital to scale innovative ideas into global enterprises.
Amplify Capital
A B Corp certified firm that invests in transformational technologies aimed at solving large-scale challenges in health, climate, and education.
What's next for BioIntelligence Technologies?
With the successful closure of this major enterprise-level funding, BioIntelligence Technologies is poised to transition into a phase of rapid commercial expansion and product iteration. The strategic roadmap likely involves scaling the deployment of its BiOptic+ and BioAnalyst platforms to meet the growing demand for precision in bioprocessing. Furthermore, the company is expected to utilize this financial runway to deepen its R&D capabilities, potentially integrating more advanced machine learning models to further automate the optimization of fermentation workflows. As the firm continues to attract institutional backing, its focus will remain on establishing itself as the standard-bearer for data-centric biomanufacturing, ultimately driving significant value for its stakeholders and the broader life sciences industry.
See full BioIntelligence Technologies company page
